Ældre patienter En populationsfarmakokinetisk analyse af HIV- inficerede patienter viste, at farmakokinetikken for darunavir ikke er meget anderledes i aldersgruppen 18- 75 år vurderet hos HIV- inficerede patienter (se pkt.
Elderly Population pharmacokinetic analysis in HIV infected patients showed that darunavir pharmacokinetics are not considerably different in the age range (18 to 75 years) evaluated in HIV infected patients (see section 4.4).